Why This Test is Important
- Determines patient eligibility for targeted therapies like crizotinib.
- Enhances treatment success rates compared to traditional chemotherapy.
- Provides precise insights into the tumor's genetic profile.
Book ROS1 Rearrangement Test | Lahalak Medical Platform
Discover innovative lung cancer treatment solutions through ROS1 molecular testing. This test accurately identifies your eligibility for modern targeted therapies, ensuring a precise and personalized treatment plan for optimal health outcomes.
Scientific name: ROS1 Gene Rearrangement Testing for Lung Cancer
An advanced molecular test detecting ROS1 gene rearrangements in non-small cell lung cancer (NSCLC). It guides clinicians in selecting effective targeted therapies like crizotinib to improve patient outcomes.
Service type
Molecular laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Sample collection
- Molecular analysis
- Detailed medical report
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Individuals seeking personalized oncology treatment plans.
- Patients requiring molecular subtyping of lung tumors.
Procedure and Methodology
- Performed on tumor tissue biopsy or through liquid biopsy (blood).
- Utilizes advanced methods like FISH or Next-Generation Sequencing (NGS).
- Results guide the oncologist in selecting the most effective medication.
Conditions & Notices
- Bring previous medical reports if available
- Coordination with the treating oncologist is recommended
Medical services you might also like
